BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai Y, Chen D, Xu T. DNA Methylation Aberrant in Atherosclerosis. Front Pharmacol 2022;13:815977. [DOI: 10.3389/fphar.2022.815977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wilson HM. The intracellular signaling pathways governing macrophage activation and function in human atherosclerosis. Biochemical Society Transactions 2022. [DOI: 10.1042/bst20220441] [Reference Citation Analysis]
2 Zhang X, Wang C, He D, Cheng Y, Yu L, Qi D, Li B, Zheng F. Identification of DNA methylation-regulated genes as potential biomarkers for coronary heart disease via machine learning in the Framingham Heart Study. Clin Epigenetics 2022;14:122. [PMID: 36180886 DOI: 10.1186/s13148-022-01343-2] [Reference Citation Analysis]
3 Wang Q, Fu S, Li S, Huang X, Wang H, Hashmi MF. Correlation of TET-2 Levels with Disease Evaluation in AMI Patients. Contrast Media & Molecular Imaging 2022;2022:1-6. [DOI: 10.1155/2022/9983071] [Reference Citation Analysis]
4 李 晨. Atherosclerosis Research: Origin, Viewpoint and Development Trend. ACM 2022;12:4934-4950. [DOI: 10.12677/acm.2022.125716] [Reference Citation Analysis]